Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Jessica N. Mezzanotte(The Ohio State University Wexner Medical Center), Maryam B. Lustberg(Yale Cancer Center), Namrata Vilas Shinde(The Ohio State University Wexner Medical Center), Michael Grimm, Timiya S. Nolan(University of Alabama at Birmingham), Lise Worthen‐Chaudhari(The Ohio State University Wexner Medical Center), Nicole Williams(The Ohio State University)
Cited by 76
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Triple-negative breast cancer: promising prognostic biomarkers currently in development
|Expert Review of Anticancer Therapy|2020|236